A double blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID) (Q43470687)
scientific article published on November 1, 1997
Language:
(P31) (Q13442814)
(P304) 167-173
(P407) (Q1860)
(P433) 2
(P478) 110
(P577) Saturday, November 1, 1997
Saturday, November 1, 1997
(P921) (Q269829)
(Q1472818)
(P953) https://academic.oup.com/cei/article-pdf/110/2/167/42205755/j.1365-2249.1997.tb08313.x.pdf
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2249.1997.tb08313.x
https://academic.oup.com/cei/article-pdf/110/2/167/42205755/j.1365-2249.1997.tb08313.x.pdf
(P1433) (Q15716708)
(P1476) "A double blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID)" (language: en)
"A double-blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID)" (language: en)
(P2093) J. A. Rump
A. Jahreis
M. Schlesier
S. Stecher
H. H. Peter
(P2860) (Q41119480)
(Q52058335)
(Q52055577)
(Q33901807)
(Q30453877)
(Q36314571)
(Q39603037)
(Q46441748)
(Q38666547)
(Q38224771)
(Q37783124)
(Q41772037)
(Q52073768)
(Q36021838)
(Q52071263)
(Q69266294)
(Q72656302)
(Q72665955)
(Q72667369)
(Q72769479)
(Q72675824)
(Q72385486)
(Q71641062)
(Q72169066)
(Q72580494)
(Q71917552)
(Q71808632)
(Q71938425)
(Q73093702)
(Q69366949)
(Q69737044)
(Q69737116)
(Q68223811)
(Q68025969)
(Q72876330)
(Q68470690)
(Q95797755)
other details
description scientific article published on November 1, 1997

External Links